Onconetix, Inc. — Director's Dealing 2022

May 27, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Blue Water Vaccines Inc. (BWV)
CIK: 0001782107
Period of Report: 2022-05-04

Reporting Person: Murphy Kimberly M (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-04	Stock Option	$6.45	A	4655	Acquired	2032-05-04	Common Stock, par value $0.00001 per share (4655)	Direct

Footnotes

F1: Stock options (the "Options") were granted to Ms. Murphy on May 4, 2022. The Options vest and become exercisable as follows: (i) 774 of the Options vested immediately upon grant; (ii) 388 Options vest at the end of each calendar month from the date of issuance through February 28, 2023; and (iii) the remaining 389 Options vest on March 31, 2023.